The present invention is directed to a composition for treating fungal skin infections along with skin rejuvenation. More particularly the present invention relates to a pharmaceutical cream comprising a biopolymer and an antifungal active ingredient. It discloses a composition for treating fungal skin infections along with skin rejuvenation containing a) a biopolymer in the form of chitosan b) an active pharmaceutical ingredient (API) composition in the form of clotrimazole used in treating fun...

The present invention is directed to a composition for treating fungal skin infections & skin inflammation along with skin rejuvenation containing a) a biopolymer in the form of Chitosan b) a combination of active pharmaceutical ingredients (APIs) namely Clotrimazole & Fluticasone Propionate used in treating fungal skin infections & skin inflammations c) a cream base containing primary and secondary emulsifiers waxy materials co -solvents acids preservatives buffering agents anti oxidants chelat...

The present invention is directed to a medicinal composition for treating skin inflammations fungal/bacterial skin infections and related wounds and also other skin wounds including those caused by burns. The cream also causes skin rejuvenation through an epithelisation process. The cream comprises a) a biopolymer in the form of Chitosan b) active Pharmaceutical Ingredients (APIs) in the form of fusidic acid that has been generated in situ from sodium fusidate Mometasone furoate & clotrimazole c...

The present invention is directed to a composition for treating fungal skin infections along with skin rejuvenation. More particularly the present invention relates to a pharmaceutical cream comprising a biopolymer and an antifungal active ingredient. It discloses a composition for treating fungal skin infections along with skin rejuvenation containing a) a biopolymer in the form of chitosan b) an active pharmaceutical ingredient (API) composition in the form of clotrimazole used in treating fun...

The present invention is directed to a composition for treating fungal skin infections & skin inflammation along with skin rejuvenation containing a) a biopolymer in the form of Chitosan b) a combination of active pharmaceutical ingredients (APIs) namely Clotrimazole & Fluticasone Propionate used in treating fungal skin infections & skin inflammations c) a cream base containing primary and secondary emulsifiers waxy materials co -solvents acids preservatives buffering agents anti oxidants chelat...

The invention discloses a dermaceutical cream containing Clobetasol Propionate as a steroid Clotrimazole as an antifungal and an antibacterial agent in the form of Fusidic acid which Fusidic acid is formed in situ from Sodium Fusidate as the starting raw material wherein Sodium Fusidate is converted into Fusidic acid under oxygen-free environment. The cream of the present invention has greater shelf-life stability and the finer particle size of the API than the conventional creams containing Fus...

The invention discloses a dermaceutical cream containing Fluticasone Propionate as a corticosteroid an antifungal agent in the form of Clotrimazole and an antibacterial agent in the form of Fusidic acid which Fusidic acid is formed in situ from Sodium Fusidate as the starting raw material wherein Sodium Fusidate is converted into Fusidic acid under oxygen-free environment. The cream of the present invention has greater shelf-life stability and the finer particle size of the API than the conventi...

The invention discloses a dermaceutical cream containing Mometasone Furoate as a corticosteroid an antifungal agent in the form of Clotrimazole and an antibacterial agent in the form of Fusidic acid which Fusidic acid is formed in situ from Sodium Fusidate as the starting raw material wherein Sodium Fusidate is converted into Fusidic acid under oxygen-free environment. The cream of the present invention has greater shelf-life stability and the finer particle size of the API than the conventional...